Gerald T Stanewick - Net Worth and Insider Trading

Gerald T Stanewick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gerald T Stanewick owns 1 companies in total, including Adhera Therapeutics Inc (ATRX) .

Click here to see the complete history of Gerald T Stanewick’s form 4 insider trades.

Insider Ownership Summary of Gerald T Stanewick

Ticker Comapny Transaction Date Type of Owner
ATRX Adhera Therapeutics Inc 2004-06-09 director

Gerald T Stanewick Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gerald T Stanewick Ownership Network

Ownership Network List of Gerald T Stanewick

No Data

Ownership Network Relation of Gerald T Stanewick

Insider Network Chart

Gerald T Stanewick Owned Company Details

What does Adhera Therapeutics Inc do?

Who are the key executives at Adhera Therapeutics Inc?

Gerald T Stanewick is the director of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .

Adhera Therapeutics Inc (ATRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adhera Therapeutics Inc Insider Transactions

No Available Data

Gerald T Stanewick Mailing Address

Above is the net worth, insider trading, and ownership report for Gerald T Stanewick. You might contact Gerald T Stanewick via mailing address: 4 Partridge Hill Road, Richmond Va 23233.

Discussions on Gerald T Stanewick

No discussions yet.